A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory POEMS Syndrome
Clinical trial NCT06518876 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06518876
- Sponsor
- Novatim Immune Therapeutics (Zhejiang) Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-31
- Primary completion
- 2027-12-31
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.